Expression of RPS8 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS8 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2351.72

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2042.0

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	5848.3
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	4869.6
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	4592.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	4449.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	4290.7
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	4104.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	4037.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3992.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	3970.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	3728.1
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	3545.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3409.7
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3341.7
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3205.9
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3018.1
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2993.8
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2894.6
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2851.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2844.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2838.2
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2763.9
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2723.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2670.2
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2660.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2600.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	2577.8
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2574.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2572.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2551.1
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2506.1
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2480.6
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2408.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2402.1
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2401.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2392.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2351.7
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2346.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2322.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2307.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2243.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2238.6
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2204.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2182.3
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2152.5
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2147.3
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2145.7
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2131.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2130.6
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2084.1
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2065.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2063.3
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2053.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2046.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2025.5
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1971.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1967.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1964.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1957.7
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1939.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1937.9
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1903.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1894.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1886.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1886.0
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1884.5
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1884.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1873.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1871.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1869.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1855.6
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1846.0
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1831.5
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1818.4
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1785.7
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1778.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1761.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1757.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1746.9
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1739.0
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1737.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1711.4
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1707.4
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1706.4
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1704.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1702.0
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1677.1
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1664.1
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1663.8
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1641.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1632.3
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1630.6
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1625.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1621.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1618.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1572.2
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1521.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1519.8
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1519.0
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1515.5
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1513.8
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1505.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1500.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1498.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1498.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1496.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1489.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1462.0
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1441.2
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1434.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1421.1
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1414.8
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1413.1
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1407.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1399.0
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1392.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1390.5
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1389.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1387.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1383.7
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1359.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1358.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1356.0
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1355.4
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1348.5
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1296.2
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1282.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1270.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1254.6
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1222.5
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1174.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1157.6
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1133.3
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1128.7
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1107.5
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1090.4
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1076.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1049.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1025.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	975.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	734.4
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	677.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS8 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 743.51

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

675.0

Number of samples

Samples

Sample	Description	pTPM
AK043	N, NA, stage:NA, alive, 660 days	1549.5
AK066	N, NA, stage:NA, alive, 960 days	1411.0
AK139	N, NA, stage:NA, dead, 270 days	1319.1
AK142	N, NA, stage:NA, alive, 90 days	1307.8
AK051	N, NA, stage:NA, dead, 360 days	1050.3
AK002	N, NA, stage:NA, dead, 570 days	1036.0
AK124	N, NA, stage:NA, alive, 1920 days	963.2
AK133	N, NA, stage:NA, dead, 360 days	951.9
AK165	N, NA, stage:NA, alive, 360 days	934.7
AK185	N, NA, stage:NA, alive, 330 days	901.5
AK213	N, NA, stage:NA, alive, 2010 days	888.4
AK072	N, NA, stage:NA, dead, 150 days	879.4
AK236	N, NA, stage:NA, dead, 360 days	868.5
AK231	N, NA, stage:NA, dead, 240 days	821.1
AK183	N, NA, stage:NA, alive, 360 days	806.3
AK049	N, NA, stage:NA, dead, 180 days	796.6
AK178	N, NA, stage:NA, dead, 240 days	766.4
AK199	N, NA, stage:NA, alive, 1860 days	759.2
AK098	N, NA, stage:NA, dead, 660 days	753.4
AK188	N, NA, stage:NA, alive, 420 days	753.1
AK156	N, NA, stage:NA, dead, 330 days	733.9
AK074	N, NA, stage:NA, alive, 300 days	727.1
AK195	N, NA, stage:NA, dead, 390 days	724.4
AK088	N, NA, stage:NA, dead, 360 days	695.4
AK055	N, NA, stage:NA, dead, 240 days	660.7
AK071	N, NA, stage:NA, dead, 540 days	607.1
AK153	N, NA, stage:NA, dead, 240 days	604.8
AK041	N, NA, stage:NA, alive, 810 days	601.1
AK205	N, NA, stage:NA, dead, 120 days	592.5
AK068	N, NA, stage:NA, alive, 360 days	588.0
AK216	N, NA, stage:NA, dead, 360 days	581.0
AK134	N, NA, stage:NA, dead, 360 days	579.1
AK053	N, NA, stage:NA, dead, 300 days	574.7
AK081	N, NA, stage:NA, dead, 180 days	561.3
AK173	N, NA, stage:NA, dead, 180 days	560.9
AK079	N, NA, stage:NA, dead, 210 days	544.3
AK035	N, NA, stage:NA, dead, 210 days	525.9
AK015	N, NA, stage:NA, alive, 720 days	515.9
AK030	N, NA, stage:NA, dead, 120 days	500.2
AK158	N, NA, stage:NA, dead, 360 days	496.8
AK218	N, NA, stage:NA, dead, 180 days	492.1
AK167	N, NA, stage:NA, dead, 180 days	489.6
AK089	N, NA, stage:NA, dead, 330 days	474.8
AK123	N, NA, stage:NA, dead, 180 days	470.8
AK076	N, NA, stage:NA, alive, 660 days	468.9
AK100	N, NA, stage:NA, alive, 960 days	460.8
AK103	N, NA, stage:NA, alive, 1320 days	459.9
AK091	N, NA, stage:NA, dead, 210 days	459.9
AK003	N, NA, stage:NA, dead, 600 days	459.2
AK149	N, NA, stage:NA, dead, 420 days	446.1
AK102	N, NA, stage:NA, alive, 1740 days	409.6
AK227	N, NA, stage:NA, alive, 300 days	401.4
AK005	N, NA, stage:NA, dead, 240 days	396.3
AK099	N, NA, stage:NA, dead, 420 days	396.1
AK117	N, NA, stage:NA, dead, 210 days	392.9
AK085	N, NA, stage:NA, alive, 660 days	360.0
AK006	N, NA, stage:NA, dead, 360 days	332.8
AK226	N, NA, stage:NA, dead, 360 days	289.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206230003	Tumor	1.0
CPT0182580003	Tumor	0.9
CPT0127480003	Tumor	0.8
CPT0219080004	Tumor	0.8
CPT0206560003	Tumor	0.7
CPT0218690004	Tumor	0.7
CPT0190360004	Tumor	0.7
CPT0205450004	Tumor	0.7
CPT0205570003	Tumor	0.6
CPT0168380003	Tumor	0.6
CPT0206880003	Tumor	0.6
CPT0162100003	Tumor	0.5
CPT0224540004	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0087570003	Tumor	0.5
CPT0162020003	Tumor	0.5
CPT0224390004	Tumor	0.5
CPT0093360003	Tumor	0.5
CPT0206110003	Tumor	0.4
CPT0125510003	Tumor	0.4
CPT0189650004	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0221180003	Tumor	0.4
CPT0127420003	Tumor	0.4
CPT0205780003	Tumor	0.3
CPT0168590003	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0217880003	Tumor	0.3
CPT0182500003	Tumor	0.3
CPT0064890003	Tumor	0.3
CPT0078580003	Tumor	0.2
CPT0216920008	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0218330004	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0087730003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0196850003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0168080003	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0189460003	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0206780003	Tumor	0.0
CPT0217060003	Tumor	0.0
CPT0189850004	Tumor	-0.1
CPT0171580008	Tumor	-0.1
CPT0093510003	Tumor	-0.1
CPT0093450003	Tumor	-0.1
CPT0218830004	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0161730003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0089150003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0123530003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0217100003	Tumor	-0.2
CPT0093550003	Tumor	-0.3
CPT0204380003	Normal	-0.3
CPT0201710003	Tumor	-0.3
CPT0189570004	Tumor	-0.3
CPT0218960004	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0207090003	Tumor	-0.4
CPT0168720003	Tumor	-0.4
CPT0167750004	Tumor	-0.4
CPT0168480003	Tumor	-0.4
CPT0092440003	Tumor	-0.4
CPT0087680003	Tumor	-0.5
CPT0189250003	Tumor	-0.5
CPT0224330003	Tumor	-0.5
CPT0218670003	Tumor	-0.5
CPT0207030003	Tumor	-0.6
CPT0104220003	Tumor	-0.6
CPT0093590003	Tumor	-0.6
CPT0204360003	Normal	-0.6
CPT0104330003	Tumor	-0.6
CPT0167860004	Tumor	-0.6
CPT0218770003	Tumor	-0.7
CPT0209440003	Tumor	-0.7
CPT0204390003	Normal	-0.7
CPT0204340003	Normal	-0.7
CPT0204370003	Normal	-0.8
CPT0199770003	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0162140003	Tumor	-0.9
CPT0204410003	Normal	-0.9
CPT0204420003	Normal	-1.1
CPT0206330003	Tumor	-1.1
CPT0190240004	Tumor	-1.1
CPT0204330003	Normal	-1.3
CPT0204400003	Normal	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis